| Outgoing Relation(s) |
| keratolytic drug (CHEBI:50176) is a dermatologic drug (CHEBI:50177) |
| Incoming Relation(s) |
| all-trans-acitretin (CHEBI:50173) has role keratolytic drug (CHEBI:50176) |
| all-trans-retinoic acid (CHEBI:15367) has role keratolytic drug (CHEBI:50176) |
| 9-cis-retinoate (CHEBI:78630) has role keratolytic drug (CHEBI:50176) |
| 9-cis-retinoic acid (CHEBI:50648) has role keratolytic drug (CHEBI:50176) |
| dibenzothiophene (CHEBI:23681) has role keratolytic drug (CHEBI:50176) |
| etretinate (CHEBI:4913) has role keratolytic drug (CHEBI:50176) |
| glycolic acid (CHEBI:17497) has role keratolytic drug (CHEBI:50176) |
| isotretinoin (CHEBI:6067) has role keratolytic drug (CHEBI:50176) |
| podophyllotoxin (CHEBI:50305) has role keratolytic drug (CHEBI:50176) |
| salicylic acid (CHEBI:16914) has role keratolytic drug (CHEBI:50176) |
| sodium glycolate (CHEBI:132094) has role keratolytic drug (CHEBI:50176) |
| talarozole (CHEBI:101854) has role keratolytic drug (CHEBI:50176) |
| tazarotene (CHEBI:32184) has role keratolytic drug (CHEBI:50176) |
| tazarotenic acid (CHEBI:73129) has role keratolytic drug (CHEBI:50176) |
| tetrahydroxy-1,4-benzoquinone (CHEBI:137472) has role keratolytic drug (CHEBI:50176) |
